Skip to main content
The Markets by Proactive
Go to Proactive Australia

Pharma & Biotech

Bioxyne gets ready to raise

The halt will remain in place until Wednesday 19th April 2017.

Bioxyne (ASX:BXN) has been granted a trading halt by the ASX, pending details of a capital raising.

The halt will remain in place until the opening of trade on Wednesday 19th April 2017, or earlier if an announcement is made to the market.